Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Fengyu Xu

Matched on OpenAlex author ID A5114135130. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2018: 1 paper · 2019: 3 papers · 2020: 1 paper · 2021: 4 papers · 2022: 1 paper

Papers 10

  1. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of … Co-author DOI 10.1186/s13046-022-02285-6↗
  2. Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Co-author DOI 10.1038/s41388-021-01960-w↗
  3. LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3/ZNF24/VEGFA pathway. Co-author DOI 10.1038/s41419-021-04119-3↗
  4. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway. Co-author DOI 10.1158/0008-5472.can-21-0281↗
  5. LncRNA-ZFAS1 Induces Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells During Nutrient Deprivation by Promoting AMPK-Mediated Phosphorylation and St… Co-author DOI 10.21203/rs.3.rs-875697/v1↗
  6. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer. Co-author DOI 10.7150/thno.49147↗
  7. Nutrient Stress-Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression. Co-author DOI 10.1158/0008-5472.can-18-0419↗
  8. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. Co-author DOI 10.7150/thno.30988↗
  9. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α. First author DOI 10.7150/thno.34559↗
  10. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Co-author DOI 10.1038/s41388-018-0382-1↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhu Zeng · 9 shared papers, 2018–2022 · strength 0.89
  2. Yuhang Hu · 7 shared papers, 2019–2022 · strength 0.76
  3. Gang Zhao · 8 shared papers, 2018–2021 · strength 0.75
  4. Chunyou Wang · 6 shared papers, 2018–2021 · strength 0.53
  5. Ye Zeng · 5 shared papers, 2018–2021 · strength 0.42
  6. Shi-Jiang Deng · 4 shared papers, 2018–2019 · strength 0.32
  7. Mingliang Liu · 4 shared papers, 2018–2019 · strength 0.32
  8. Shuai Zhu · 3 shared papers, 2018–2021 · strength 0.25
  9. Wei Li · 2 shared papers, 2020–2021 · strength 0.21
  10. Peng Xu · 2 shared papers, 2020–2021 · strength 0.19
  11. Shichang Deng · 2 shared papers, 2018–2019 · strength 0.15
  12. Qiang Li · 2 shared papers, 2018–2019 · strength 0.15
  13. Gang Zhao · 1 shared paper, 2022 · strength 0.14
  14. Wenfeng Zhuo · 1 shared paper, 2022 · strength 0.14
  15. Gang Zhao · 1 shared paper, 2021 · strength 0.11
  16. Qiang Li · 1 shared paper, 2019 · strength 0.09
  17. Zhi Fang · 1 shared paper, 2020 · strength 0.09
  18. Wei Li · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.